ANGO Stock Price, Chart, Stats & News

AngioDynamics, Inc.
Save
553.67M
Market cap
–
Current P/E
96.15x
Forward P/E
ANGO chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 53.72% |
Operating margin | -9.41% |
Pretax margin | -9.02% |
Net margin | -9.02% |
Effective tax rate | 0.01% |
ROA | -10.28% |
ROE | -15.31% |
D/E | – |
Interest coverage ratio | -272.72x |
ANGO valuation
P/E | – |
P/S | 1.46x |
P/B | 2.56x |
P/CF | -80.58x |
P/FCF | -48.16x |
P/OCF | -80.58x |
PEG | -1.15x |
EV multiple | -145.28x |
About
AngioDynamics, Inc. specializes in the development, manufacturing, and commercialization of a diverse array of medical, surgical, and diagnostic instruments. These products are utilized by healthcare professionals to address conditions such as peripheral vascular disease, facilitate vascular access, and support various oncology and surgical interventions, serving both domestic and international markets. The company's portfolio includes advanced ablation systems like NanoKnife, designed for the precise surgical removal of soft tissues, and Solero microwave and radiofrequency systems, effective in ablating solid cancerous or benign growths.
Similar securities
Based on sector and market capitalization
Report issue











